Article Information
History
- August 29, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Simran Samra1,2,
- Mehul Sharma1,
- Maryam Vaseghi-Shanjani1,2,
- Kate L. Del Bel1,
- Loryn Byres1,
- Susan Lin1,
- Joshua Dalmann1,
- Areesha Salman1,
- Jill Mwenifumbo3,
- Bhavi P. Modi1,
- Catherine M. Biggs1,
- Cyrus Boelman1,
- Lorne A. Clarke1,3,†,
- Anna Lehman†,
- the CAUSES Study and
- Stuart E. Turvey1,*,†
- 1Department of Pediatrics, BC Children’s Hospital, The University of British Columbia, Vancouver V6H 3N1, Canada
- 2Experimental Medicine Program, Department of Medicine, The University of British Columbia, Vancouver V5Z 1M9, Canada
- 3Department of Medical Genetics, BC Children’s Hospital, The University of British Columbia, Vancouver V6H 3N1, Canada
- ↵*Correspondence to: Stuart E. Turvey, MBBS, DPhil, FRCPC BC Children’s Hospital 950 West 28th Avenue Vancouver, BC, V5Z 4H4, Canada Phone: 604 875 2345 ext. 5094 Email: sturvey{at}cw.bc.ca
↵† Denotes equal contribution as senior authors
Posted August 29, 2023.
Gain-of-function MARK4 variant associates with pediatric neurodevelopmental disorder and dysmorphism
